Article Versions Notes

Schümann FL, Groß E, Bauer M, Rohde C, Sandmann S, Terziev D, Müller LP, Posern G, Wienke A, Fend F, et al. Divergent Effects of EZH1 and EZH2 Protein Expression on the Prognosis of Patients with T-Cell Lymphomas. Biomedicines. 2021; 9(12):1842. https://doi.org/10.3390/biomedicines9121842

Schümann, Franziska Lea, Elisabeth Groß, Marcus Bauer, Christian Rohde, Sarah Sandmann, Denis Terziev, Lutz P. Müller, Guido Posern, Andreas Wienke, Falko Fend, and et al. 2021. "Divergent Effects of EZH1 and EZH2 Protein Expression on the Prognosis of Patients with T-Cell Lymphomas" Biomedicines 9, no. 12: 1842. https://doi.org/10.3390/biomedicines9121842

Schümann, F. L., Groß, E., Bauer, M., Rohde, C., Sandmann, S., Terziev, D., Müller, L. P., Posern, G., Wienke, A., Fend, F., Hansmann, M.-L., Klapper, W., Rosenwald, A., Stein, H., Dugas, M., Müller-Tidow, C., Wickenhauser, C., Binder, M., & Weber, T. (2021). Divergent Effects of EZH1 and EZH2 Protein Expression on the Prognosis of Patients with T-Cell Lymphomas. Biomedicines, 9(12), 1842. https://doi.org/10.3390/biomedicines9121842